Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations

Journal Article · · PLoS ONE
 [1];  [2];  [3];  [4];  [5];  [6];  [7];  [8];  [4];  [9];  [4];  [3];  [7];  [5];  [10];  [2]
  1. University of Chicago, IL (United States); DOE/OSTI
  2. Children’s Hospital Oakland Research Institute, Oakland, CA (United States)
  3. Pfizer Global Research and Development, Groton, CT (United States)
  4. Harvard Medical School, Boston, MA (United States)
  5. Washington University, St. Louis, MO (United States)
  6. Marshfield Clinic Research Foundation, Marshfield, WI (United States)
  7. Cedars-Sinai Medical Center, West Los Angeles, CA (United States)
  8. Medical College of Wisconsin, Milwaukee, WI (United States)
  9. Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
  10. University of Chicago, IL (United States)
Statins effectively lower total and plasma LDL-cholesterol, but the magnitude of decrease varies among individuals. To identify single nucleotide polymorphisms (SNPs) contributing to this variation, we performed a combined analysis of genome-wide association (GWA) results from three trials of statin efficacy. Bayesian and standard frequentist association analyses were performed on untreated and statin-mediated changes in LDL-cholesterol, total cholesterol, HDL-cholesterol, and triglyceride on a total of 3932 subjects using data from three studies: Cholesterol and Pharmacogenetics (40 mg/day simvastatin, 6 weeks), Pravastatin/ Inflammation CRP Evaluation (40 mg/day pravastatin, 24 weeks), and Treating to New Targets (10 mg/day atorvastatin, 8 weeks). Genotype imputation was used to maximize genomic coverage and to combine information across studies. Phenotypes were normalized within each study to account for systematic differences among studies, and fixed-effects combined analysis of the combined sample were performed to detect consistent effects across studies. Two SNP associations were assessed as having posterior probability greater than 50%, indicating that they were more likely than not to be genuinely associated with statin-mediated lipid response. SNP rs8014194, located within the CLMN gene on chromosome 14, was strongly associated with statin-mediated change in total cholesterol with an 84% probability by Bayesian analysis, and a p-value exceeding conventional levels of genome-wide significance by frequentist analysis (P = 1.8 x 10-8 ). This SNP was less significantly associated with change in LDL-cholesterol (posterior probability = 0.16, P = 4.0 x 10-6 ). Bayesian analysis also assigned a 51% probability that rs4420638, located in APOC1 and near APOE, was associated with change in LDL-cholesterol. Using combined GWA analysis from three clinical trials involving nearly 4,000 individuals treated with simvastatin, pravastatin, or atorvastatin, we have identified SNPs that may be associated with variation in the magnitude of statin-mediated reduction in total and LDL-cholesterol, including one in the CLMN gene for which statistical evidence for association exceeds conventional levels of genome-wide significance.
Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
Donald W. Reynolds Foundation; National Center for Research Resources (NCRR); National Institutes of Health (NIH); Pfizer; USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1627401
Journal Information:
PLoS ONE, Journal Name: PLoS ONE Journal Issue: 3 Vol. 5; ISSN 1932-6203
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
English

References (25)

Bayes factors for genome-wide association studies: comparison withP-values journal January 2009
Calmin, a Protein with Calponin Homology and Transmembrane Domains Expressed in Maturing Spermatogenic Cells journal June 2001
Pharmacogenetic study of statin therapy and cholesterol reduction journal August 2004
Polymorphisms of the HNF1A Gene Encoding Hepatocyte Nuclear Factor-1α are Associated with C-Reactive Protein journal May 2008
Phenotypic Predictors of Response to Simvastatin Therapy Among African-Americans and Caucasians: The Cholesterol and Pharmacogenetics (CAP) Study journal March 2006
Polymorphisms Associated With Cholesterol and Risk of Cardiovascular Events journal June 2008
Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels journal November 2005
A second generation human haplotype map of over 3.1 million SNPs journal December 2006
Common variants at 30 loci contribute to polygenic dyslipidemia journal December 2008
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans journal January 2008
Newly identified loci that influence lipid concentrations and risk of coronary artery disease journal January 2008
Principal components analysis corrects for stratification in genome-wide association studies journal July 2006
Bayesian statistical methods for genetic association studies journal October 2009
Clinical implications of pharmacogenomics of statin treatment journal March 2006
Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins journal September 2002
Use of Unlinked Genetic Markers to Detect Population Stratification in Association Studies journal July 1999
A Bayesian Measure of the Probability of False Discovery in Genetic Epidemiology Studies journal August 2007
Characterization of cDNA Clones Selected by the GeneMark Analysis from Size-Fractionated cDNA Libraries from Human Brain journal January 1999
Genomic Control for Association Studies journal December 1999
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines journal August 2004
Common Genetic Variation inABCA1Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease journal March 2001
Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort journal April 2009
Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment journal March 2008
Imputation-based analysis of association studies: candidate regions and quantitative traits journal January 2005
Practical Issues in Imputation-Based Association Mapping journal December 2008

Cited By (92)

Evolutionary history of disease‐susceptibility loci identified in longitudinal exome‐wide association studies journal August 2019
Whole-exome sequencing identified four loci influencing craniofacial morphology in northern Han Chinese journal April 2019
Patterns of statin use and cholesterol goal attainment in a high-risk cardiovascular population: A retrospective study of primary care electronic medical records journal January 2016
Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis journal June 2014
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy journal August 2013
A comprehensive study of metabolite genetics reveals strong pleiotropy and heterogeneity across time and context journal October 2019
The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change journal January 2020
Detecting signals in pharmacogenomic genome-wide association studies journal January 2014
A polymorphism in HLA-G modifies statin benefit in asthma journal September 2014
Erratum: Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner journal May 2016
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study journal October 2012
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols journal January 2015
Pharmacogenomic personalised medicine for antiplatelet agents is on the horizon journal June 2012
Obesity and African Americans: Physiologic and Behavioral Pathways journal January 2013
Fast and Accurate Genome-Wide Association Test of Multiple Quantitative Traits journal January 2018
Pharmacogenetic Determinants of Statin-Induced Reductions in C-Reactive Protein journal February 2012
Genome-Wide Association Study Evaluating Lipoprotein-Associated Phospholipase A 2 Mass and Activity at Baseline and After Rosuvastatin Therapy journal December 2012
Pharmacogenomics: The Genetics of Variable Drug Responses journal April 2011
Atherosclerosis Susceptibility Loci Identified in an Extremely Atherosclerosis‐Resistant Mouse Strain journal August 2013
Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses journal October 2011
Impact of APOE gene polymorphisms on the lipid profile in an Algerian population journal October 2013
Analysis of the progression of systolic blood pressure using imputation of missing phenotype values journal June 2014
In silico pathway analysis and tissue specific cis-eQTL for colorectal cancer GWAS risk variants journal May 2017
Analysis of genetic and nongenetic factors influencing triglycerides-lowering drug effects based on paired observations journal September 2018
The influence of the intestinal microflora to the efficacy of Rosuvastatin journal June 2018
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation journal September 2014
Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a) journal May 2012
Bayesian variable selection regression for genome-wide association studies and other large-scale problems journal September 2011
Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene journal July 2012
RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin journal November 2012
Population-specific genetic modification of Huntington's disease in Venezuela journal May 2018
Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach journal January 2017
Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment journal October 2011
Gene-Wide Characterization of Common Quantitative Trait Loci for ABCB1 mRNA Expression in Normal Liver Tissues in the Chinese Population journal September 2012
SNP@lincTFBS: An Integrated Database of Polymorphisms in Human LincRNA Transcription Factor Binding Sites journal July 2014
A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians journal April 2015
A novel iterative mixed model to remap three complex orthopedic traits in dogs journal June 2017
KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment journal October 2018
CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin journal June 2015
Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects journal April 2017
Current Genomics in Cardiovascular Medicine journal August 2012
The role of SNP-loop diuretic interactions in hypertension across ethnic groups in HyperGEN journal January 2013
Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response journal August 2016
Influence of APOE and RNF219 on Behavioral and Cognitive Features of Female Patients Affected by Mild Cognitive Impairment or Alzheimer’s Disease journal April 2018
Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins journal January 2017
Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond journal November 2019
Applicability of Precision Medicine Approaches to Managing Hypertension in Rural Populations journal April 2018
Integrative modeling of eQTLs and cis-regulatory elements suggest mechanisms underlying cell type specificity of eQTLs text January 2012
Gene Polymorphism and Coronary Heart Disease book March 2012
Effects of Different Types of Statins on Lipid Profile: A Perspective on Asians
  • Meor Anuar Shuhaili, Meor Fairuz Rizal; Samsudin, Intan Nureslyna; Stanslas, Johnson
  • International Journal of Endocrinology and Metabolism, Vol. In Press, Issue In Press https://doi.org/10.5812/ijem.43319
journal April 2017
Quality Control Procedures for Genome‐Wide Association Studies journal January 2011
Poly-Omic Prediction of Complex Traits: OmicKriging journal May 2014
A genetic stochastic process model for genome-wide joint analysis of biomarker dynamics and disease susceptibility with longitudinal data journal June 2017
Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia
  • Maxwell, Whitney D.; Ramsey, Laura B.; Johnson, Samuel G.
  • Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Vol. 37, Issue 9 https://doi.org/10.1002/phar.1981
journal August 2017
Stroke Pharmacogenetics book July 2012
Stroke Pharmacogenetics book January 2017
Gene-environment interactions and obesity traits among postmenopausal African-American and Hispanic women in the Women’s Health Initiative SHARe Study journal November 2012
Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk journal October 2014
Comparative analysis of the gut microbiota in distinct statin response patients in East China journal November 2018
Gene–Diet Interactions on Lipid Levels: Current Knowledge in the Era of Genome-Wide Association Studies journal June 2012
Pharmacogenetic Advances in Cardiovascular Medicine: Relevance to Personalized Medicine journal January 2013
Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease journal July 2013
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins journal October 2014
ZNF542P is a pseudogene associated with LDL response to simvastatin treatment journal August 2018
Mapping genes that predict treatment outcome in admixed populations journal October 2010
En route to precision medicine through the integration of biological sex into pharmacogenomics journal February 2017
Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene journal September 2019
A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application? journal July 2011
HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism journal September 2013
Fine-mapping of lipid regions in global populations discovers ethnic-specific signals and refines previously identified lipid loci journal November 2016
The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 journal November 2018
mTADA: a framework for analyzing de novo mutations in multiple traits posted_content January 2018
Operating Characteristics of the Rank-Based Inverse Normal Transformation for Quantitative Trait Analysis in Genome-Wide Association Studies posted_content January 2019
Operating characteristics of the rank‐based inverse normal transformation for quantitative trait analysis in genome‐wide association studies journal January 2020
GWAS of 126,559 Individuals Identifies Genetic Variants Associated with Educational Attainment journal May 2013
Pharmacogenomics and Patient Care: One Size Does Not Fit All journal September 2012
Using Adipose Measures from Health Care Provider-Based Imaging Data for Discovery journal September 2018
Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial journal April 2012
SOX5 Is a Candidate Gene for Chronic Obstructive Pulmonary Disease Susceptibility and Is Necessary for Lung Development journal June 2011
Detecting responses to treatment with fenofibrate in pedigrees journal September 2018
Interactions between Glucocorticoid Treatment and Cis-Regulatory Polymorphisms Contribute to Cellular Response Phenotypes journal July 2011
Quantile-Specific Penetrance of Genes Affecting Lipoproteins, Adiposity and Height journal January 2012
The influence of gut microbiota on drug metabolism and toxicity journal November 2015
Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies journal March 2013
Applicability of precision medicine approaches to managing hypertension in rural populations text January 2018
Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach text January 2017
Gene-environment interactions and obesity traits among postmenopausal African-American and Hispanic women in the Women’s Health Initiative SHARe Study
  • Ibukun, Kusimo,; Jo, O’Sullivan, Mary; R., Velez Edwards, Digna
  • The University of North Carolina at Chapel Hill University Libraries https://doi.org/10.17615/9v2g-4581
text January 2013
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins text January 2014
Fine-mapping of lipid regions in global populations discovers ethnic-specific signals and refines previously identified lipid loci text January 2016
Applicability of Precision Medicine Approaches to Managing Hypertension in Rural Populations posted_content January 2018
Pharmacogenomics of lipid-lowering therapies journal June 2013
Population-specific genetic modification of Huntington's disease in Venezuela text January 2018

Similar Records

Simvastatin mitigates increases in risk factors for and the occurrence of cardiac disease following 10 Gy total body irradiation
Journal Article · Sun May 31 20:00:00 EDT 2015 · Pharmacology Research & Perspectives · OSTI ID:1213431

Toxicokinetics and toxicity of atorvastatin in dogs
Journal Article · Sat Nov 14 23:00:00 EST 2015 · Toxicology and Applied Pharmacology · OSTI ID:22687817

Atorvastatin ameliorates arsenic-induced hypertension and enhancement of vascular redox signaling in rats
Journal Article · Sat Nov 01 00:00:00 EDT 2014 · Toxicology and Applied Pharmacology · OSTI ID:22439891